IS7805A - Drying process - Google Patents

Drying process

Info

Publication number
IS7805A
IS7805A IS7805A IS7805A IS7805A IS 7805 A IS7805 A IS 7805A IS 7805 A IS7805 A IS 7805A IS 7805 A IS7805 A IS 7805A IS 7805 A IS7805 A IS 7805A
Authority
IS
Iceland
Prior art keywords
drying process
drying
Prior art date
Application number
IS7805A
Other languages
Icelandic (is)
Other versions
IS3028B (en
Inventor
Mayeresse Yves
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32234471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7805(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0225520.6A external-priority patent/GB0225520D0/en
Priority claimed from GB0225532A external-priority patent/GB0225532D0/en
Priority claimed from GB0225543A external-priority patent/GB0225543D0/en
Priority claimed from GB0317381A external-priority patent/GB0317381D0/en
Priority claimed from GB0317380A external-priority patent/GB0317380D0/en
Priority claimed from GB0317371A external-priority patent/GB0317371D0/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of IS7805A publication Critical patent/IS7805A/en
Publication of IS3028B publication Critical patent/IS3028B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Sampling And Sample Adjustment (AREA)
IS7805A 2002-11-01 2005-04-18 Drying method IS3028B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB0225520.6A GB0225520D0 (en) 2002-11-01 2002-11-01 Drying process
GB0225532A GB0225532D0 (en) 2002-11-01 2002-11-01 Drying process
GB0225543A GB0225543D0 (en) 2002-11-01 2002-11-01 Immunogenic composition
GB0317381A GB0317381D0 (en) 2003-07-24 2003-07-24 Drying method
GB0317380A GB0317380D0 (en) 2003-07-24 2003-07-24 Drying method
GB0317371A GB0317371D0 (en) 2003-07-24 2003-07-24 Immunogenic composition

Publications (2)

Publication Number Publication Date
IS7805A true IS7805A (en) 2005-04-18
IS3028B IS3028B (en) 2021-05-15

Family

ID=32234471

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7805A IS3028B (en) 2002-11-01 2005-04-18 Drying method
IS7806A IS7806A (en) 2002-11-01 2005-04-18 Immunogenic composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7806A IS7806A (en) 2002-11-01 2005-04-18 Immunogenic composition

Country Status (28)

Country Link
US (3) US8409587B2 (en)
EP (3) EP2395073B1 (en)
JP (2) JP4579156B2 (en)
KR (2) KR101058978B1 (en)
AR (2) AR041880A1 (en)
AT (1) ATE352316T1 (en)
AU (2) AU2003287980B2 (en)
BR (1) BR0315767A (en)
CA (2) CA2503946C (en)
CY (2) CY1119504T1 (en)
DE (1) DE60311526T2 (en)
DK (2) DK2395073T3 (en)
ES (3) ES2649048T3 (en)
HK (1) HK1085380A1 (en)
HU (1) HUE034801T2 (en)
IL (2) IL168052A (en)
IS (2) IS3028B (en)
LT (2) LT2395073T (en)
MA (2) MA27551A1 (en)
MX (3) MX343419B (en)
MY (2) MY132859A (en)
NO (3) NO342741B1 (en)
NZ (2) NZ539706A (en)
PL (2) PL213647B1 (en)
PT (2) PT1556477T (en)
SI (2) SI2395073T1 (en)
TW (2) TWI332843B (en)
WO (2) WO2004039417A2 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2649048T3 (en) 2002-11-01 2018-01-09 Glaxosmithkline Biologicals S.A. Drying procedure
RU2418633C2 (en) * 2004-04-08 2011-05-20 Байоматрика, Инк. Integration of specimens storage and control in biomedical sciences
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
US20080176209A1 (en) * 2004-04-08 2008-07-24 Biomatrica, Inc. Integration of sample storage and sample management for life science
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
TWI398272B (en) 2005-03-08 2013-06-11 Intervet Int Bv Chemically defined stabiliser
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
KR101408113B1 (en) * 2005-06-27 2014-06-16 글락소스미스클라인 바이오로지칼즈 에스.에이. Process for manufacturing vaccines
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5214464B2 (en) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション Delivery medium for probiotic bacteria, in the form of glass, comprising a dry matrix of polysaccharides, saccharides and polyols and method for producing the same
AU2007293673B2 (en) † 2006-09-07 2013-06-27 Glaxosmithkline Biologicals S.A. Vaccine
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
EP2142211A1 (en) 2007-05-02 2010-01-13 GlaxoSmithKline Biologicals S.A. Vaccine
CN101755044B (en) * 2007-05-18 2014-06-11 米迪缪尼有限公司 Preservation of bioactive materials by freeze dried foam
CA2690164A1 (en) * 2007-06-16 2008-12-24 Enigma Diagnostics Limited Compositions
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
KR101540920B1 (en) * 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 Antigen-adjuvant compositions and methods
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
JP5841527B2 (en) 2009-05-26 2016-01-13 アドバンスド バイオニュートリション コーポレーション Stable dry powder composition comprising biologically active microorganisms and / or bioactive materials and method for producing the same
EP2475393A4 (en) * 2009-09-14 2013-08-21 Vu Truong-Le Formulation for room temperature stabilization of a live attenuated bacterial vaccine
CN102725393B (en) 2010-01-28 2015-12-02 先进生物营养公司 Comprise the dry glass matter composition of biological active materials
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
FR2960781B1 (en) * 2010-06-07 2013-11-22 Sanofi Pasteur PREPARATION OF STABILIZED DRY ORAL VACCINE COMPOSED OF ATTENUATED LIVE VIRUS
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
EP2598661B1 (en) 2010-07-26 2017-09-27 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
SG187250A1 (en) 2010-08-13 2013-03-28 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
BR112013005049A2 (en) 2010-09-02 2016-05-31 Sanofi Pasteur stabilizer for the preparation of an injectable dry polio vaccine composition
WO2012075379A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Liquid viral formulations
AU2011336410B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Lyophilized viral formulations
US8512679B2 (en) 2011-03-04 2013-08-20 Elwha Llc Glassy compositions
AU2012243126A1 (en) * 2011-04-07 2013-10-17 Glaxosmithkline Llc Formulations with reduced viscosity
SG193963A1 (en) * 2011-04-07 2013-11-29 Glaxosmithkline Llc Formulations with reduced viscosity
EP2524701A3 (en) 2011-05-20 2012-12-19 Nitto Denko Corporation Pharmaceutical composition and method for producing the same
SG11201401360XA (en) 2011-10-25 2014-05-29 Onclave Therapeutics Ltd Antibody formulations and methods
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
CN105530955A (en) * 2013-10-03 2016-04-27 日东电工株式会社 Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation
EP3082769B1 (en) * 2013-12-19 2018-01-31 Janssen Vaccines & Prevention B.V. Improved formulations for virosomes
MX2016009991A (en) 2014-02-11 2016-10-07 Massachusetts Inst Technology Novel full spectrum anti-dengue antibody.
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
AR101256A1 (en) * 2014-07-21 2016-12-07 Sanofi Pasteur VACCINE COMPOSITION THAT INCLUDES IPV AND CYCLODEXTRINES
EP3317395B1 (en) 2015-06-30 2020-07-15 Société des Produits Nestlé S.A. Composition suitable for protecting microorganisms
DK3328215T3 (en) 2015-07-29 2021-09-13 Advanced Bionutrition Corp STABLE DRY PROBIOTIC COMPOSITIONS FOR SPECIFIC DIETARY USES
KR20200000497A (en) * 2015-09-04 2020-01-02 인벤트프라이즈 엘엘씨 Vlp stabilized vaccine compositions
CN113588501A (en) 2015-12-08 2021-11-02 生物马特里卡公司 Reducing erythrocyte sedimentation rate
MX2019002489A (en) 2016-09-02 2019-10-21 Sanofi Pasteur Inc Neisseria meningitidis vaccine.
US20210379186A1 (en) * 2018-04-16 2021-12-09 Merck Patent Gmbh Additives for protein formulations to improve thermal stability
AU2019345595A1 (en) * 2018-09-28 2021-04-15 Otsuka Pharmaceutical Factory,Inc. Mammal cell preserving solution containing acarbose or stachyose

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US509893A (en) * 1893-12-05 William griesser
DE1157734B (en) 1961-08-16 1963-11-21 Behringwerke Ag Process for the production of stable, orally administered poliomyelitis virus preparations
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
US3929132A (en) * 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
DE3071552D1 (en) 1979-09-21 1986-05-22 Hitachi Ltd Semiconductor switch
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
GB8323094D0 (en) * 1983-08-26 1983-09-28 Franks F Preservation of cells
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
IT1187753B (en) 1985-07-05 1987-12-23 Sclavo Spa GLYCOPROTEIC CONJUGATES WITH TRIVALENT IMMUNOGENIC ACTIVITY
US4891319A (en) 1985-07-09 1990-01-02 Quadrant Bioresources Limited Protection of proteins and the like
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8715238D0 (en) 1987-06-29 1987-08-05 Quadrant Bioresources Ltd Food process
GB8801338D0 (en) 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DE3819530A1 (en) * 1988-06-08 1989-12-21 Westphal Geb Jauch Christel Dr Process, carrier and test kit for the cultivation and microscopic examination of cells
JP3237842B2 (en) 1988-12-16 2001-12-10 オランダ国 Pneumolysin mutants and pneumococcal vaccines produced therefrom
ZA907737B (en) 1989-09-29 1991-07-31 Nisshin Oil Mills Ltd Stable immunogen composition for oral administration
JPH03161441A (en) 1989-11-20 1991-07-11 Senjiyu Seiyaku Kk Maillard reaction inhibitor
DE69133276T2 (en) 1990-07-16 2003-11-27 Univ North Carolina ANTIGENT IRON-SUPPRESSING PROTEINS OF THE N. MENINGITIS RELATED TO THE HEMOLYSIN TOXINE FAMILY
US5912336A (en) 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
DE69133334T2 (en) 1990-08-23 2004-05-13 University Of North Carolina At Chapel Hill PROFERIN BINDING TRANSFERRIN FROM NEISSERIA-GONORRHOEAE AND NEISSERIA-MENINGITIDIS
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
FR2682041B1 (en) 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins VACCINE AGAINST NEISSERIA MENINGITIDIS INFECTIONS.
IT1253009B (en) 1991-12-31 1995-07-10 Sclavo Ricerca S R L DETOXIFIED IMMUNOGENIC MUTANTS OF COLERIC TOXIN AND TOXIN LT, THEIR PREPARATION AND USE FOR THE PREPARATION OF VACCINES
CA2129899C (en) 1992-02-11 2011-01-04 James J. Mond Dual carrier immunogenic construct
AU3630093A (en) 1992-03-02 1993-10-05 Biocine S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
IT1262896B (en) 1992-03-06 1996-07-22 CONJUGATE COMPOUNDS FORMED FROM HEAT SHOCK PROTEIN (HSP) AND OLIGO-POLY-SACCHARIDES, THEIR USE FOR THE PRODUCTION OF VACCINES.
EP0835663B1 (en) 1992-05-23 2009-09-30 GlaxoSmithKline Biologicals S.A. Combined vaccines comprising Hepatitis B surface antigen and other antigens
FR2692592B1 (en) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc DNA fragments encoding the Neisseria meningitidis transferrin receptor subunits and methods of expressing them.
DE69323264D1 (en) 1992-10-27 1999-03-11 American Cyanamid Co Pediatric combination vaccine with improved immunogenicity of each vaccine component
EP1300156A3 (en) 1993-05-18 2003-05-07 The Ohio State University Research Foundation Otitis media vaccine
WO1996004931A1 (en) 1994-08-09 1996-02-22 The Nisshin Oil Mills, Ltd. Peroral immunogen composition and process for producing the same
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur Proteinase k resistant surface protein of neisseria meningitidis
CA2222455C (en) 1995-03-22 2013-05-28 Smithkline Beecham Biologicals S.A. A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US6265567B1 (en) 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
US5843464A (en) 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
BR9608612A (en) 1995-06-07 1999-05-04 Smithkline Beecham Biolog Vaccine comprising a polysaccharide antigen conjugate - carrier protein and free carrier protein
JPH11507214A (en) 1995-06-07 1999-06-29 バイオケム ヴァシーンズ インク． Heat shock protein members of streptococci belonging to the HSP70 family
BR9609188A (en) 1995-06-07 1999-05-11 Quadrant Holdings Cambridge Methods for stably incorporating substances into dry foamed glass matrices and compositions thus obtained
DE19543770C2 (en) 1995-11-24 1998-11-05 Metallgesellschaft Ag Device for measuring condensed moisture in devices and / or pipelines in chemical engineering and their use
WO1997029773A1 (en) * 1996-02-13 1997-08-21 The Nisshin Oil Mills, Ltd. Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same
ATE323721T1 (en) 1996-05-01 2006-05-15 Univ Rockefeller CHOLINE-BINDING PROTEIN USED AS AN PNEUMOCOCCAL VACCINE
AU3214597A (en) * 1996-05-29 1998-01-05 Universal Preservation Technologies, Inc. Long-term shelf preservation by vitrification
US5766520A (en) 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
EP1762246A1 (en) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Multivalent DTP-Polio vaccines
FR2751000B1 (en) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med SPECIFIC DNA FROM NEISSERIA MENINGITIDIS BACTERIA, PROCESSES FOR OBTAINING THEM AND BIOLOGICAL APPLICATIONS
DE19630390A1 (en) 1996-07-26 1998-01-29 Chiron Behring Gmbh & Co Proteins, in particular membrane proteins from Helicobacter pylori, their production and use
US5882896A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5882871A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
EP0941335A2 (en) 1996-10-31 1999-09-15 Human Genome Sciences Streptococcus pneumoniae polynucleotides and sequences
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
SE511963C2 (en) 1997-04-23 1999-12-20 Ericsson Telefon Ab L M Device and method for determining line voltage in a subscriber line circuit
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
KR100619350B1 (en) 1997-07-21 2006-09-05 박스터 헬쓰케어 에스.에이. Modified immunogenic pneumolysin compositions as vaccines
GB9717953D0 (en) 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
CA2303105A1 (en) 1997-09-15 1999-03-25 Pasteur Merieux Msd Multivalent vaccines
BR9814878A (en) 1997-11-21 2000-10-03 Genset Sa Genetic sequence and polypeptides of chlamydia pneumoniae, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
WO1999027071A1 (en) * 1997-11-26 1999-06-03 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
KR100735651B1 (en) 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
AU1979599A (en) 1998-01-14 1999-08-02 Chiron S.P.A. (neisseria meningitidis) antigens
GB9806456D0 (en) 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition
EP1067962B1 (en) 1998-04-07 2010-03-24 MedImmune, LLC Derivatives of pneumococcal choline binding proteins for vaccines
GB9807721D0 (en) 1998-04-08 1998-06-10 Chiron Spa Antigen
BR9910089A (en) 1998-05-01 2004-06-08 Chiron Corp Compositions and antigens of neisseria meningitidis
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2004511201A (en) 1998-10-09 2004-04-15 カイロン　コーポレイション Neisseria genome sequences and methods of using them
CA2347849C (en) 1998-10-22 2013-06-25 The University Of Montana Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
WO2000027994A2 (en) 1998-11-12 2000-05-18 The Regents Of The University Of California Chlamydia pneumoniae genome sequence
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
CZ303653B6 (en) 1999-03-19 2013-01-30 Smithkline Beecham Biologicals S. A. Immunogenic composition
US6245568B1 (en) 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
WO2000061761A2 (en) 1999-04-09 2000-10-19 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
DK1233784T3 (en) 1999-12-02 2008-09-01 Novartis Vaccines & Diagnostic Preparations and Methods for Stabilizing Biological Molecules after Lyophilization
PT2289545T (en) 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Supplemented omv vaccine against meningococcus
PT2270030E (en) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Heterologous expression of neisserial proteins
PT1296715E (en) 2000-06-29 2012-01-19 Smithkline Beecham Biolog Multivalent vaccine composition
EP1297005B1 (en) 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
KR100385711B1 (en) * 2000-07-05 2003-05-27 녹십자백신 주식회사 The quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen and the preparation thereof
MXPA03003690A (en) 2000-10-27 2004-05-05 Chiron Spa Nucleic acids and proteins from streptococcus groups a b.
RU2323002C2 (en) 2001-07-26 2008-04-27 Чирон Срл. Vaccines comprising aluminum adjuvants and histidine
WO2003087327A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
ES2649048T3 (en) 2002-11-01 2018-01-09 Glaxosmithkline Biologicals S.A. Drying procedure
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
US9473463B2 (en) 2014-07-29 2016-10-18 Combined Conditional Access Development & Support, LLC Control word and associated entitlement control message caching and reuse

Also Published As

Publication number Publication date
CA2503946C (en) 2016-08-16
WO2004039417A2 (en) 2004-05-13
AU2003278166B2 (en) 2009-01-29
EP2395073A2 (en) 2011-12-14
KR20050084626A (en) 2005-08-26
PL377170A1 (en) 2006-01-23
PT1556477T (en) 2017-11-14
NZ539613A (en) 2008-09-26
ATE352316T1 (en) 2007-02-15
MY132859A (en) 2007-10-31
DE60311526T2 (en) 2007-10-31
KR101130948B1 (en) 2012-03-30
WO2004039417A3 (en) 2004-12-16
EP1575612B1 (en) 2007-01-24
US8449865B2 (en) 2013-05-28
CA2503871C (en) 2012-12-11
AU2003278166A1 (en) 2004-05-25
US8409587B2 (en) 2013-04-02
MXPA05004528A (en) 2005-07-26
MA27551A1 (en) 2005-10-03
SI2395073T1 (en) 2017-12-29
US20110159038A1 (en) 2011-06-30
CA2503871A1 (en) 2004-05-13
EP2395073B1 (en) 2017-09-06
JP2006504801A (en) 2006-02-09
LT2395073T (en) 2017-11-10
ES2645924T3 (en) 2017-12-11
MXPA05004675A (en) 2005-06-08
NO20051998D0 (en) 2005-04-25
NO20051998L (en) 2005-06-24
IL168054A (en) 2011-06-30
CY1119504T1 (en) 2018-03-07
MA27644A1 (en) 2005-12-01
PL376950A1 (en) 2006-01-09
IS3028B (en) 2021-05-15
CA2503946A1 (en) 2004-05-13
HUE034801T2 (en) 2018-02-28
IL168052A (en) 2015-03-31
JP2006512406A (en) 2006-04-13
NO20052010L (en) 2005-06-24
LT1556477T (en) 2017-10-25
TWI332843B (en) 2010-11-11
IL168052A0 (en) 2011-08-01
US20060127414A1 (en) 2006-06-15
AR041880A1 (en) 2005-06-01
AU2003287980A1 (en) 2004-05-25
DK2395073T3 (en) 2017-10-23
TW200501981A (en) 2005-01-16
NO20180874A1 (en) 2005-06-24
PL213647B1 (en) 2013-04-30
EP1575612A1 (en) 2005-09-21
MX343419B (en) 2016-11-04
NO20052010D0 (en) 2005-04-25
KR101058978B1 (en) 2011-08-23
MY145693A (en) 2012-03-30
EP2395073A3 (en) 2012-01-25
NO344759B1 (en) 2020-04-14
AU2003287980B2 (en) 2009-06-25
EP1556477B1 (en) 2017-08-09
TW200501980A (en) 2005-01-16
AR041881A1 (en) 2005-06-01
PT2395073T (en) 2017-11-24
HK1085380A1 (en) 2006-08-25
US7927858B2 (en) 2011-04-19
WO2004039399A1 (en) 2004-05-13
NO342741B1 (en) 2018-08-06
SI1556477T1 (en) 2017-12-29
JP4579156B2 (en) 2010-11-10
PL215237B1 (en) 2013-11-29
ES2280809T3 (en) 2007-09-16
IS7806A (en) 2005-04-18
DK1556477T3 (en) 2017-10-23
CY1119362T1 (en) 2018-03-07
BR0315767A (en) 2005-09-06
US20060127415A1 (en) 2006-06-15
NZ539706A (en) 2008-03-28
DE60311526D1 (en) 2007-03-15
EP1556477A2 (en) 2005-07-27
ES2649048T3 (en) 2018-01-09
KR20050075766A (en) 2005-07-21

Similar Documents

Publication Publication Date Title
IS7805A (en) Drying process
DK1531673T3 (en) Hitherto unknown 2-pyridylethylbenzamide derivative
DE60212275D1 (en) Drier
DE50311534D1 (en) GEWEBEBAND SETUP
DE502004004375D1 (en) DRIER
DE60326724D1 (en) STRUCTURING PROCESS
FI20020479A (en) Coating Process
DE60227910D1 (en) clothes dryer
DE50302710D1 (en) clothes dryer
DE50203350D1 (en) printing process
FI20031304A0 (en) dryer
NO20041043L (en) Procedure for washing objects
DE60331878D1 (en) printing process
DE60209395D1 (en) Collection dryer
GB0225520D0 (en) Drying process
SE0202568D0 (en) New process
SE0201004D0 (en) New process
SE0202041D0 (en) Novel process
SE0201363D0 (en) Novel process
NO20043433L (en) Approach
ITMI20020305V0 (en) CLOTHES
FIU20020336U0 (en) drying Rack
UA6425S (en) DECORATIONS FOR CLOTHES
FI20031162A0 (en) Dry Process System
FI20031623A0 (en) Dry Process System